These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25558509)

  • 1. [Evaluation and socio-economic relevance of an integrated osteoporosis health care network].
    Pfeifer M; Hinz Ch; Lazarescu AD; Minne HW
    Versicherungsmedizin; 2014 Dec; 66(4):198-201. PubMed ID: 25558509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and economic burden of osteoporosis in Switzerland.
    Svedbom A; Ivergård M; Hernlund E; Rizzoli R; Kanis JA
    Arch Osteoporos; 2014; 9():187. PubMed ID: 24970672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E
    Osteoporos Int; 2016 Jan; 27(1):387-96. PubMed ID: 26576544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Male osteoporosis].
    Farahmand P; Spiegel R; Ringe JD
    Z Rheumatol; 2016 Jun; 75(5):459-65. PubMed ID: 27117306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.
    Chandran M; Lau TC; Gagnon-Arpin I; Dobrescu A; Li W; Leung MYM; Patil N; Zhao Z
    Arch Osteoporos; 2019 Nov; 14(1):114. PubMed ID: 31773442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis medication and reduced mortality risk in elderly women and men.
    Center JR; Bliuc D; Nguyen ND; Nguyen TV; Eisman JA
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1006-14. PubMed ID: 21289270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients.
    Schray D; Neuerburg C; Stein J; Gosch M; Schieker M; Böcker W; Kammerlander C
    Eur J Trauma Emerg Surg; 2016 Oct; 42(5):559-564. PubMed ID: 27458065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost of fractures in German hospitals--what role does osteoporosis play?].
    Bleibler F; Benzinger P; Lehnert T; Becker C; König HH
    Gesundheitswesen; 2014 Mar; 76(3):163-8. PubMed ID: 23709102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy].
    Jakob F; Seefried L; Schwab M
    Internist (Berl); 2014 Jul; 55(7):755-61. PubMed ID: 24903137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures.
    Goltz L; Degenhardt G; Maywald U; Kirch W; Schindler C
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):263-70. PubMed ID: 23296590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of osteoporosis].
    Fassbender WJ; Willmann B
    Dtsch Med Wochenschr; 2014 Mar; 139(10):497-500. PubMed ID: 24570199
    [No Abstract]   [Full Text] [Related]  

  • 14. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis, diagnosis and treatment of osteoporosis in men].
    Rabijewski M; Papierska L; Zgliczyński W
    Pol Merkur Lekarski; 2008 Jan; 24(139):76-80. PubMed ID: 18634259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Osteoporosis Management in Primary Care: An Audit of the Impact of a Community Based Fracture Liaison Nurse.
    Chan T; de Lusignan S; Cooper A; Elliott M
    PLoS One; 2015; 10(8):e0132146. PubMed ID: 26313924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.
    Yates CJ; Chauchard MA; Liew D; Bucknill A; Wark JD
    J Clin Densitom; 2015; 18(2):150-6. PubMed ID: 25797867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fewer hip fractures with risedronate versus alendronate in the first year of treatment: modeled German cost-effectiveness analysis.
    Thompson M; Pasquale M; Grima D; Moehrke W; Kruse HP
    Value Health; 2010; 13(1):46-54. PubMed ID: 19883401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic treatment of osteoporosis--2011].
    Lakatos P
    Orv Hetil; 2011 Aug; 152(33):1320-6. PubMed ID: 21824859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.